Jade Biosciences (JBIO) Shares Outstanding (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Shares Outstanding data on file, last reported at $49.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 1243.55% year-over-year to $49.3 million; the trailing twelve-month figure through Mar 2026 stood at $49.3 million (up 1243.55% YoY), and the FY2025 full-year result was $49.3 million, up 1242.75% from the prior year.
• Shares Outstanding for Q1 2026 stood at $49.3 million, roughly flat from $49.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $49.3 million in Q1 2026 and bottomed at $12622.0 in Q2 2025.
• The 5-year median for Shares Outstanding is $24.5 million (2022), against an average of $19.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding jumped 9945.6%; it then tumbled 86.84% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $24.7 million in 2022, then climbed by 12.3% to $27.8 million in 2023, then tumbled by 86.77% to $3.7 million in 2024, then surged by 1242.75% to $49.3 million in 2025, then gained by 0.06% to $49.3 million in 2026.
• The last three Shares Outstanding figures came in at $49.3 million (Q1 2026), $49.3 million (Q4 2025), and $32.6 million (Q3 2025), per Business Quant data.

Peer Comparison